期刊文献+

维生素D与乳腺癌骨转移研究进展 被引量:5

下载PDF
导出
摘要 乳腺癌是女性常见恶性肿瘤,骨转移发生率约为65%~75%。一旦发生骨转移,将伴有病理性骨折、脊髓压迫、高钙血症、剧烈疼痛等,严重影响患者生存质量。近来研究发现维生素D不仅能降低乳腺癌患病率、复发率和死亡率,还可降低乳腺癌骨转移的发生率。现将相关研究作如下综述。
出处 《实用医学杂志》 CAS 北大核心 2012年第21期3666-3668,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献20

  • 1Peppone L J, Huston A J, Reid M E, et al. The effect of various vitamin D supplementation regimens in breast cancer patients [J]. Breast Cancer Res Treat, 2011,127 (1) : 171-177. 被引量:1
  • 2Bortman P, Folgueira M A, Katayama M L, et al. Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a minireview [J]. Braz J Med Bio Res, 2002,35 ( 1 ) : 1-9. 被引量:1
  • 3Chakraborti C K. Vitamin D as a promising anticancer agent [J]. Indian J Pharmacol, 2011,43(2) : 113-120. 被引量:1
  • 4Morrison M A, Silveira A C, Huynh N, et al. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age- related macular degeneration [J]. Hum Genomics, 2011,5 (6) : 538-568. 被引量:1
  • 5Crew K D, Shane E, Cremers S, et al. High prevalence of vitamin D deficiency despite supplementation in premeno- pausal women with breast cancer undergoing adjuvant chemotherapy [J]. J Clin Oneol, 2009,27 (13):2151- 2156. 被引量:1
  • 6Vashi P G, Trukova K, Lammersfeld C A, et al. Impact of oral vitamin D supplementation on serum 25 - hydroxyvitamin D levels in oncology [J]. Nutr J, 2010,9:60. 被引量:1
  • 7Trukova K P, Grutsch J, Lammersfeld C, et al. Prevalence of vitamin D insufficiency among breast cancer survivors [J]. Nutr Clin Pract, 2012, 27( 1 ) : 122-128. 被引量:1
  • 8Lopes N, Carvalho J, Duries C, et al. 1Alpha, 25-dihydroxyvitamin D3 induces de novo E-cadherin expressionin triple-negative breast cancer cells by CDHl-promoter demethylation [J]. Anticancer Res, 2012,32 (1):249- 257. 被引量:1
  • 9刘静,赵浩亮.1,25二羟维生素D_3与三苯氧胺对乳腺癌细胞生长及凋亡的影响[J].中国药物与临床,2007,7(7):534-535. 被引量:3
  • 10Sergeev I N. Vitamin D and cellular Ca2+ signaling in breast cancer [J]. Anticancer Res, 2012,32 (1):299- 302. 被引量:1

二级参考文献4

  • 1Ercoli A,Scambia G.Comparative study on the indication of eytostasis and apoptosis by ICI182780 and tamoxifen in an estrogen receptor-negative ovarian cancer cell line.Int J Cancer,1998,76:47-54. 被引量:1
  • 2Barbareschi M,Veronese S,Caffo O,et al.bcl-2 and p53 expression in node-negative breast carcinoma:a study with long term follow-up.Hum Pathol,1996,27:1149-1155. 被引量:1
  • 3Issa LL Leong GM,Eisman JA.Molecular mechanism of vitamin D receptor action.Adv Exp Med Biol,1996,399:53-70. 被引量:1
  • 4Wang TIY.Phang JM.Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7.Cancer Res,1995,55:2487-2489. 被引量:1

共引文献2

同被引文献51

  • 1KARANIKOLAS B D,FIGUEIREDO M L,WU L.Polycomb group protein enhancer of zeste2is an oncogene that promotes the neo-plastic transformation of a benign prostatic epithelial cell line[J].Mol Cancer Res,2009,7:1456-1465. 被引量:1
  • 2BREUER R H,SNIJDERS P J,SMIT E F,et al.Increased expres-sion of the EZH2polycomb group gene in BMI-l-positive neo-plastic cells during bronchial carcinogenesis[J].Neoplasia,2004,6(6):736-743. 被引量:1
  • 3WEIKERT S,CHRISTOPH F,KOLLERMANN J,et al.Expression levels of the EZH2polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas[J].Int J Mol Med,2005,16(2):349-353. 被引量:1
  • 4ARISAN S,BUYUKTUNCER E D,PALAVAN-UNSAL N,et al.Increased expression of EZH2,a polycomb group protein,in blad-der carcinoma[J].Urol Int,2005,75(3):252-257. 被引量:1
  • 5CARDOSO C,MIGNON C,HETET G,et al.The human EZH2 gene:genomic organization and revised mapping in7q35within the critical region for malignant myeloid disorders[J].Eur J Hum Genet,2000,8(3):174-180. 被引量:1
  • 6KLEER C G,CAO Q,VARAMBALLY S,et al.EZH2is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells[J].Proc Natl Acad Sci USA,2003,100(20):11606-11611. 被引量:1
  • 7RAAPHORST F M,MEIJER C J,FIERET E,et al.Poorly differen-tiated breast carcinoma is associated with increased expression of human polycomb group EZH2gene[J].Neoplasia,2003,5(6):481-488. 被引量:1
  • 8VARAMBALLY S,DHANASEKARAN S M,ZHOU M,et al.The polycomb grop protein EZH2is involved inprogression of prostate cancer[J].Nature,2002,419(6907):624-629. 被引量:1
  • 9ZETTER B R,BANYARD J CANCER.The silence of the genes[J].Nature,2002,419(6907):572-573. 被引量:1
  • 10SUDO T,UTSUNOMIYA T,MIMORI K,et al.Clinicopathological significance of EZH2mRNA expression in patients with hepatocel-lular carcinoma[J].Br J Cancer,2005,92(9):1754-1758. 被引量:1

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部